3.8 Review

Thioredoxin reductase -: Two modes of catalysis have evolved

期刊

EUROPEAN JOURNAL OF BIOCHEMISTRY
卷 267, 期 20, 页码 6110-6117

出版社

WILEY
DOI: 10.1046/j.1432-1327.2000.01702.x

关键词

flavoprotein; thioredoxin; thioredoxin reductase; selenium; disulfide; dithiol; selenenylsulfide; redox active; ribonucleotide reductase; transcription factor activation; drug design

资金

  1. NIGMS NIH HHS [GM16429, GM18723, GM21444] Funding Source: Medline

向作者/读者索取更多资源

Thioredoxin reductase (EC 1.6.4.5) is a widely distributed flavoprotein that catalyzes the NADPH-dependent reduction of thioredoxin. Thioredoxin plays several key roles in maintaining the redox environment of the cell. Like all members of the enzyme family that includes lipoamide dehydrogenase, glutathione reductase and mercuric reductase, thioredoxin reductase contains a redox active disulfide adjacent to the flavin ring. Evolution has produced two forms of thioredoxin reductase, a protein in prokaryotes, archaea and lower eukaryotes having a M-r of 35 000, and a protein in higher eukaryotes having a M-r of 55 000. Reducing equivalents are transferred from the apolar flavin binding site to the protein substrate by distinct mechanisms in the two forms of thioredoxin reductase. In the low M-r enzyme, interconversion between two conformations occurs twice in each catalytic cycle. After reduction of the disulfide by the flavin, the pyridine nucleotide domain must rotate with respect to the flavin domain in order to expose the nascent dithiol for reaction with thioredoxin; this motion repositions the pyridine ring adjacent to the flavin ring. In the high M-r enzyme, a third redox active group shuttles the reducing equivalent from the apolar active site to the protein surface. This group is a second redox active disulfide in thioredoxin reductase from Plasmodium falciparum and a selenenylsulfide in the mammalian enzyme. P. falciparum is the major causative agent of malaria and it is hoped that the chemical difference between the two high M-r forms may be exploited for drug design.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据